Cardiovascular Health Topics

The On-Topic Netowork

Cardiovascular Health > Stroke


Stroke
Stroke
Stroke
Stroke
Stroke

The following information is about Stroke.

Stroke Defined

Occurs when blood vessels in the brain either become clogged or burst, killing vital tissue. Can result in temporary or permanent disabilities including paralysis and a variety of sensory impairments.

This definition is in context to Cardiovascular Health. See more contextual defintions for Stroke.


Navigation: [ 1 2 3 4 5 Next ]

Prof Elected to Royal Society of Canada

Published September 5, 2008, 12:12 pm, University of Guelph News

A University of Guelph scientist renowned for his work on the role of muscle activity in metabolic diseases has been elected to the Royal Society of Canada, considered Canada's senior academic honour. Prof. Arend Bonen, a faculty member in the Department of Human Health and Nutritional Sciences and a Canada Research Chair in Metabolism and Health, is among 72 new fellows named this week. He ...

Full Story


Quick Shots "“ Local Edition

Published September 5, 2008, 10:06 am, Georgetown Record

A listing of local sports announcements, as well as some from towns just beyond Georgetown for the week beginning Sept. 4.

Full Story


Walk for a healthy heart

Published September 5, 2008, 8:11 am, The Reporter

BRIDGEWATER -- Eric Niebling, general manager of Global Pharmaceutical Supply Group in Raritan, will lead this year's Start! Somerset-Hunterdon County Walk, scheduled for Saturday, Oct. 4 at Duke Island Park in Bridgewater.

Full Story


Little suckers clear the path to the brain

Published September 5, 2008, 7:22 am, Goulburn Post

WHEN Mehdi Jaffari was told his left carotid artery was so severely blocked he faced the risk of an imminent stroke, he turned the clock back to medieval times.

Full Story


NeurAxon's NXN-188 Demonstrates Pain Relief in Migraine with Aura

Published September 5, 2008, 6:37 am, Centre Daily Times

NeurAxon, Inc., a developer of next-generation pain therapeutics targeting neuronal nitric oxide synthase (nNOS), today announced data from its Phase 2 clinical trial of NXN-188 in patients with migraine. In the study, patients experiencing migraine with aura, which represents over 7 million patients in the US, achieved sustained relief from their headaches, representing a potentially ...

Full Story


NeurAxon's NXN-188 Demonstrates Pain Relief in Migraine with Aura

Published September 5, 2008, 5:45 am, Business Wire via Yahoo! Finance

WALTHAM, Mass.----NeurAxon, Inc., a developer of next-generation pain therapeutics targeting neuronal nitric oxide synthase , today announced data from its Phase 2 clinical trial of NXN-188 in patients with migraine.

Full Story


Inhaled Treprostinil New Drug Application Filed By FDA

Published September 5, 2008, 5:16 am, Medical News Today

United Therapeutics Corporation (Nasdaq: UTHR) and its wholly-owned subsidiary Lung Rx, Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for inhaled treprostinil for the treatment of pulmonary arterial hypertension.

Full Story


Pathway Medical Technologies Receives FDA Clearance for Jetstream(TM) Pathway PV(TM) Atherectomy System

Published September 5, 2008, 4:59 am, Marketwire via Yahoo! Finance

Pathway Medical Technologies, Inc., an innovator of endovascular treatments for peripheral arterial disease, today announced that the U.S. Food & Drug Administration has given the company clearance to market Jetstream(TM), a peripheral atherectomy catheter designed for use in the treatment of PAD in the lower limbs.

Full Story


Aetna Signs Contract with Central Florida Health Alliance

Published September 5, 2008, 4:53 am, Business Wire via Yahoo! Finance

ORLANDO, Fla.----Aetna announced today that it has reached agreement with the Central Florida Health Alliance on a three-year contract that adds Leesburg Regional Medical Center and The Villages Regional Hospital to Aetna's provider network in the Central Florida area.

Full Story


Cytokinetics Announces the Initiation of Third Phase IIa Clinical Trial of CK-1827452

Published September 5, 2008, 4:30 am, Marketwire via Yahoo! Finance

Cytokinetics, Incorporated announced today the initiation of its third Phase IIa clinical trial evaluating CK-1827452, a novel cardiac myosin activator being developed by the company for the potential treatment of patients with either acutely decompensated or chronic heart failure. CK-1827452 is the subject of a Collaboration and Option Agreement between Cytokinetics and Amgen Inc.

Full Story


Navigation: [ 1 2 3 4 5 Next ]

Are you looking for additional Cardiovascular Health > Stroke news? Try our new "Stroke News Focus" area.

Off-site Stroke Links, User Submitted

The following links have been collected through user bookmark submission in the Stroke category. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.

Fri Sep 5

Thu Sep 4

If you would like to find additional social bookmark based links on the topic of we recommend the Open Tag Directory > Stroke. If you would like to find related tags we recommend Tag Patterns > Stroke

Off-site Stroke Research Links

If you still need additional information on Stroke then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.

Cardiovascular Health

If you know the Cardiovascular Health Term Name use the links below to quickly jump to your desired focus.



Bookmark Us

The On Topic Network

This website is part of The On Topic Network.

Thank You

Cardiovascular-Health.On-Topic.net was developed by Odin Metatech, Inc and runs on the Odin Assemble platform.

Best Viewed With

License

Creative Commons License This work is licensed under Creative Commons.




Powered by Odin Assemble 2.5a